Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Acorai